Investigating Circulating Metabolism-Related Biomarkers and Diet in an Active Surveillance Population

Abbreviated Name
PASS Ref Set App: Caveolin-1
Lead Investigator
Lin UW, Daniel W. — University of Washington
Coordinating Investigator
Lin UW, Daniel W. — University of Washington
Involved Investigators

Abstract

No abstract availalbe.

Aims

Validate the association between Cav-1-sphingolipid signature level and progression on active surveillance using a cohort of men enrolled on a prospective active surveillance trial.

Analytic Method

No analytic method available.

Comments

No comments available.

Outcome

No outcome available.

Secure Outcome

No secure outcome available.

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
Start Date
Dec 1 2021
Estimated Finish Date
Dec 1 2022
Finish Date
Dec 31 2020
Protocol ID
501
Protocol Type
Validation
Fields of Research
  • Proteomics
Collaborative Group
Prostate and Urologic Cancers Research Group
Cancer Types
  • Malignant neoplasm of prostate

Associated Forms